跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
LIORESAL intrathecal baclofen 10mg/5mL injection ampoule
Approved
STANDARD
LIORESAL intrathecal baclofen 10mg/5mL injection ampoule
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
56aca78ebfc83327
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
56aca78ebfc83327
Product Name
LIORESAL intrathecal baclofen 10mg/5mL injection ampoule
Artg Id
53836
Artg Name
LIORESAL intrathecal baclofen 10mg/5mL injection ampoule
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
1996-03-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4d9b4016f8b17c12dbf341f48be8a007.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1b1fb117c56d9526e7423cdd81a3fa6c.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
56aca78ebfc83327
Type
Standard
Back to TGA Approvals
LIORESAL intrathecal baclofen 10mg/5mL injection ampoule - TGA Drug Approval Details
